Interchange Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Interchange Capital Partners's JAZZ Position: Q3 2026 in Review
Interchange Capital Partners opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 1,014 shares worth $235K. The stake represents 0.04% of the portfolio and ranks #388 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in JAZZ as recently as Q2 2021.
Interchange Capital Partners first reported a position in JAZZ in Q4 2020 and has held it in 3 quarters since. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Interchange Capital Partners held 1,014 shares of Jazz Pharmaceuticals worth $235K as of Q3 2026.
- Jazz Pharmaceuticals was a new Interchange Capital Partners position in Q3 2026.
- Jazz Pharmaceuticals made up 0.04% of Interchange Capital Partners's portfolio in Q3 2026, its #388 holding.
- Interchange Capital Partners first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
- 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Interchange Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.